LIXTE Biotechnology Holdings, Inc. Investor Relations The following documents have been filed with the SEC: SEC FILING ALERT DEFA14A: ADDITIONAL DEFINITIVE PROXY SOLICITING MATERIALS AND RULE 14(A)(12) MATERIAL HTML PDF If you have any questions, or would like to contact Investor Relations, please reply to this email. LIXTE Biotechnology Holdings, Inc. 680 E Colorado Blvd., Suite 180, Pasadena, CA 91101 United States of America Change Your